Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US08659B1026
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00JNGG9Q2
BBNX

Beta Bionics, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $HLTH
NAME
Beta Bionics, Inc.
ISIN
US08659B1026
TICKER
BBNX
MIC
XNAS
REUTERS
BBNX.OQ
BLOOMBERG
BBNX US
Sa., 24.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Fr., 23.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Fr., 23.10.2026       Beta Bionics

San Diego, California--(Newsfile Corp. - October 23, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Beta Bionics, Inc. (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the "Class Period"). Bet...
Fr., 23.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 23, 2026 /PRNewswire/ -- Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA). Investors...
Fr., 23.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Fr., 23.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Do., 22.10.2026       Beta Bionics

San Francisco, California--(Newsfile Corp. - October 22, 2026) - Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA).Investors who suffered substantial losses purchasing Bet...
Do., 22.10.2026       Beta Bionics

NEW YORK  , Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mai...
Do., 22.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 22, 2026) - If you suffered a loss on your investment in Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit...
Do., 22.10.2026       Beta Bionics

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws.New York, New York--(Newsfile Corp. - October 2...
Silent Ad
Do., 22.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Do., 22.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Mi., 21.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 21, 2026 /PRNewswire/ -- Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA). Investors...
Mi., 21.10.2026       Beta Bionics

Time-sensitive notice: the lawsuit asserts that Beta Bionics management described an FDA Form 483 and a subsequent FDA Warning Letter as a "very benign" difference in interpretation of reporting rules, when the agency had allegedly identified systemic quality-management and patient-safety non-conformities.NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Le...
Mi., 21.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Mi., 21.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Mi., 21.10.2026       Beta Bionics

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholde...
Mi., 21.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Di., 20.10.2026       Beta Bionics

PHILADELPHIA, Oct. 20, 2026 /PRNewswire/ -- Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 through February 24, 2026...
Di., 20.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 20, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows...
Silent Ad
Di., 20.10.2026       Beta Bionics

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws.NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Leadin...
Di., 20.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 20, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Di., 20.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Di., 20.10.2026       Beta Bionics

Beta Bionics, Inc. (NASDAQ: BBNX) shareholders should email fletcher@fmoorelaw.comNEW YORK, Oct. 19, 2026 /PRNewswire/ -- What is the Investigation About?On January 8, 2026, after the market closed, Beta Bionics reported an unexpected shortfall in new patient starts for its iLet Bion...
Mo., 19.10.2026       Beta Bionics

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3,...
Mo., 19.10.2026       Beta Bionics

SAN DIEGO, Oct. 19, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Beta Bionics, Inc. (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the "Class Period"). Beta Bionics is a comm...
Mo., 19.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Mo., 19.10.2026       Beta Bionics

Boston, Massachusetts--(Newsfile Corp. - October 19, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) and certain of its executives. Investors who have lost money in their Beta Bionics, Inc. investment should contact the firm to learn more about how they might rec...
Mo., 19.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
So., 18.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
So., 18.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Sa., 17.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If you pu...
Sa., 17.10.2026       Beta Bionics

NEW ORLEANS, Oct. 16, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NasdaqGM: BBNX), if they purchased or otherwise acquired the C...
Fr., 16.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Fr., 16.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows...
Fr., 16.10.2026       Beta Bionics

Philadelphia, Pennsylvania--(Newsfile Corp. - October 16, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 thro...
Fr., 16.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Fr., 16.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Do., 15.10.2026       Beta Bionics

San Francisco, California--(Newsfile Corp. - October 15, 2026) - Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026.The lawsuit follows a series of surprise revelations about the FDA...
Do., 15.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 15, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Do., 15.10.2026       Beta Bionics

The lawsuit contends Beta Bionics abandoned a built-in safety net for the iLet dosing algorithm and left more than 18,000 customer complaints uninvestigated, alleged operational failures that reached shareholders only after BBNX had shed 72% of its value.NEW YORK, Oct. 15, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Beta Bionics, Inc. (NAS...
Do., 15.10.2026       Beta Bionics

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail ar...
Do., 15.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Do., 15.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 14, 2026) - The law firm of Kirby McInerney LLP reminds Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) investors who acquired Beta Bionics securities between July 30, 2025 and February 24, 2026 ("the Class Period") of the November 3, 2026 deadline to seek lead plaintiff appointment...
Mi., 14.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Mi., 14.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Mi., 14.10.2026       Beta Bionics

Important information regarding Section 20(a) individual liability claims: the lawsuit alleges Beta Bionics' CEO and CFO certified SEC filings while a June 2025 FDA Form 483 citing more than 18,000 unreported iLet complaints was allegedly withheld from shareholders.NEW YORK, Oct. 14, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors i...
Mi., 14.10.2026       Beta Bionics

NEW YORK, Oct. 14, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders...
Mi., 14.10.2026       Beta Bionics

LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (...
Mi., 14.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...